lung readily accessible target organ gene therapy date therapeutic gene delivery largely focused introducing functional corrective genes lung diseases arising single gene defects cystic fibrosis recently centred gene therapy potential therapeutic tool modulating complex pathological processes pulmonary inflammation genetic modification critical components inflammatory process example overexpressing genes circumvent elastase mediated lung damage emphysema development improved viral liposome vectors evolution effective adjuvant immunosuppression obviate host immune example using selective cytokines blockers t cell surface potential exists target therapeutic doses transgene deficient dysregulated cells furthermore increased understanding promoter regions mechanisms controlling regulation gene expression offer potential close control therapeutic gene expression lung continuing refinements technologies provide new therapeutic strategies inflammatory lung disease beneficial anti elastase responses activation tissue specific